Impact of the Coronavirus (COVID-19) on Patients With Cancer
Launched by STANFORD UNIVERSITY · Mar 31, 2020
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how COVID-19 affects patients who have cancer. Researchers want to gather information through a survey to better understand the challenges and experiences faced by cancer patients during the pandemic. The study is currently looking for participants to join, and anyone aged 18 and older who is willing to share their thoughts through the survey can take part.
If you or a loved one is interested and meets the age requirement, you can expect to answer questions about your experiences with cancer and COVID-19. It's important to note that only those who can verbally agree to participate will be included in the study. This research aims to help improve care for cancer patients by learning more about their unique situations during such a challenging time.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. The patients must be 18 years or older.
- • 2. Patients who opt in to complete the survey.
- • 3. Patients must have the capacity to verbally consent for the interview.
- Exclusion Criteria:
- • 1.Patients who under the age of 18 years old.
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stanford, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials